Verme no Pancreas - Glicongoya Review and Ads Breakdown

What Is Verme no Pancreas - Glicongoya

Verme no Pancreas - Glicongoya is presented as a natural Japanese method for people struggling with uncontrolled blood sugar. The VSL does not show a conventional supplement facts panel in the provided transcript, and it does not disclose a full ingredient list, dosage table, manufacturer, price, refund policy, or product format.

What it does disclose is the concept of a mixture called Kongoya, described by Hannah Yano as a combination of seven Japanese herbs. The main herb is named as Goya, which the transcript identifies in Brazil as melao de Sao Caetano. The usage instructions in the story are simple: Carlos, Hannah's husband, is told to place a small portion of the mixture under the tongue and then drink a glass of warm water once per day before breakfast.

The opening testimonial describes a slightly different home-recipe style version. The woman says her relative sent her to buy ingredients, including a cactus that looked like ours and three little powders she already had in the kitchen. That creates some ambiguity. The VSL refers to an herbal mixture with seven Japanese herbs, but the testimonial frames it like a recipe made from household ingredients. Because the transcript does not provide a finished label or exact formulation, the safest conclusion is that the offer promotes a Japanese-inspired herbal blood sugar method, not a clearly documented ingredient formula.

The VSL positions Glicongoya as something fundamentally different from standard diabetes management. According to the presentation, the issue is not simply sweets, bread, body weight, stress, aging, or lack of exercise. The claimed issue is a parasite living silently in the pancreas. The product's job, according to the VSL, is to remove that alleged parasite.

This is the offer's unique mechanism. In direct-response marketing, a unique mechanism gives the audience a new reason why previous attempts failed. Here, the logic is: diets failed, medications failed, and glucose remained high because the audience was never targeting the real villain. The VSL says the real villain is the verme diabetico.

The Problem It Targets

The problem targeted by Glicongoya is not described in mild terms. The VSL targets people who feel cornered by diabetes, especially those who believe they have done everything correctly and still cannot stabilize their glucose.

The opening testimonial is built around this emotional state. The woman says she was diabetic, was losing vision in both eyes, had suffered for 12 years, could barely see her grandchildren's faces, left her job at a daycare, and needed her children to care for her. She says she slept afraid of waking up completely blind or eventually needing an amputation. She describes wounds that took too long to heal, feet that burned or tingled, and a lack of energy.

This is not a generic wellness pain point. The VSL is targeting the deep fear attached to diabetes complications: blindness, amputation, neuropathy, slow wound healing, and loss of independence. It also targets the frustration of compliance without reward. The testimonial says she avoided sweets, did not drink, had gone years without eating bread, took medications, and still saw glucose reach 230.

Hannah Yano's story repeats the same frustration at a higher emotional intensity. Her daughter Clara is said to have followed all the standard measures: glucose monitoring, strict diet, regular exercise, and daily use of Ozempic, metformin, and insulin. According to the presentation, Clara still had fasting glucose above 142 and post-meal spikes above 325. The VSL then says Clara died after a sudden cardiac arrest linked to diabetes complications.

The transcript uses this tragedy to deepen the stakes. Carlos, Hannah's husband, is also diabetic. After their daughter's death, his health worsens, his glucose rises, he develops diabetic neuropathy, injures his foot, and the wound becomes an ulcer. Hannah says that from her clinical experience, she believed amputation was only a matter of time.

This is the emotional ground the offer stands on. The audience is not simply being asked whether they want better numbers. They are being asked whether they are scared of becoming dependent, losing their sight, losing a limb, or watching a loved one decline. That makes the VSL's promised solution feel urgent, personal, and high stakes.

How Glicongoya Works

According to the presentation, Glicongoya works by targeting a hidden cause of diabetes: the so-called verme diabetico inside the pancreas. The VSL says this organism is also known as suizobenchu or uratrema pancreaticum. It allegedly lodges in the pancreas, attacks beta cells, sabotages insulin production, and creates insulin resistance.

The VSL's mechanism is not framed as glucose support in the cautious language common to supplement labels. It is framed as removal of an internal enemy. The presentation claims that healthy habits, exercise, and medication can only temporarily manage high blood sugar because they do not remove the parasite. In the VSL's words, the parasite leaves the root problem intact.

The story says Carlos used the mixture once daily before breakfast. For the first three days, Hannah says she noticed no change. By day seven, according to the presentation, Carlos was less weak, had less excessive thirst, and no longer had to get up as often at night to urinate. By day 12, his morning glucose, previously around 157, was allegedly stable at 110 mg/dL. After 20 days, his leg wound was said to be healing. After one month, the VSL claims his post-meal glucose was around 110 and his leg wound had healed completely.

The opening testimonial makes even more dramatic claims. The woman says her glucose began falling within one week and did not pass 118. In the second week, she says it stabilized at 90, and her vision improved. After 15 days, she claims she saw a white worm-like object in the toilet after urinating. After one month, she says she could see better, ate cake at her son's birthday, and returned to buying bread for coffee.

These are claims made by the VSL. They are not proof. The transcript does not provide clinical testing, lab reports, before-and-after medical records, microscopy, parasite identification, blinded trials, safety data, or independent verification. For an editorial review, the important point is that the VSL sells Glicongoya through a parasite-cleansing mechanism, not through a standard blood sugar support positioning.

The ad transcript reinforces this. It begins with vegetables that help slow glucose absorption because of fiber, low glycemic index, antioxidants, and flavonoids. Then it says that if the viewer already eats tomato, onion, garlic, and zucchini but glucose remains high, the problem is not food. The ad claims the problem is what is inside the pancreas. It then says a 10-second Japanese trick can clean out the parasite and make the body react.

Key Ingredients and Components

The full Glicongoya ingredient list is not disclosed in the provided transcript. That is one of the biggest practical gaps in the offer.

The main named component is Goya, which the VSL identifies as melao de Sao Caetano. The presentation calls Goya the powerful main herb in a seven-herb Japanese mixture. It does not give a Latin botanical name, plant part, extract ratio, dosage, standardization, safety warnings, or interactions.

The VSL also says the mixture contains seven Japanese herbs, but it does not name the other six. The opening testimonial mentions a cactus-like ingredient and three little powders already in the kitchen, but again, those powders are not identified. Because the transcript does not disclose the full formula, any article claiming to know the complete Glicongoya ingredients from this source would be overreaching.

In the broader blood sugar supplement category, products often include typical nutrients or botanicals such as bitter melon, cinnamon, chromium, berberine, alpha-lipoic acid, gymnema, fenugreek, magnesium, or fiber-based ingredients. However, those are typical category ingredients, not confirmed Glicongoya ingredients from this transcript. The only clearly named herb here is Goya / melao de Sao Caetano.

The product's operational components are also part of the pitch. The method is presented as sublingual, meaning a small portion is placed under the tongue. It is paired with warm water and taken before breakfast. That ritualized format matters. It makes the product feel simple, memorable, and distinct from swallowing another capsule.

The VSL's real differentiator is not the ingredient disclosure. It is the story attached to the ingredients: Japan, Nagano, longevity, ancestral herbs, a 92-year-old grandfather, an 88-year-old naturopathic doctor, and a hidden parasite that conventional medicine allegedly ignores.

The VSL Hook and Story

The Verme no Pancreas - Glicongoya VSL is built like a medical mystery story. It starts with a sufferer, introduces a hidden villain, escalates into institutional suppression, and then reveals an ancestral Japanese solution.

The first voice is a grandmother-style testimonial. She speaks in plain, emotional language. She says she followed medical advice, avoided sweets and alcohol, stopped eating bread, took medications, and still suffered. The breakthrough comes through faith and family: she says Santa Rita de Cassia placed salvation in her path, and that a relative in Japan was part of a medical research effort with a famous doctor.

This opening does several things at once. It creates identification with older Brazilian viewers. It adds religious trust. It frames the discovery as coming from family rather than an impersonal company. It also introduces the claim that Japan has very little diabetes because people there use a plant to remove the worm through urine.

Then the VSL shifts into Hannah Yano's authority narrative. She introduces herself as 53 years old, a doctor specializing in nutrition and health, trained at Johns Hopkins in Baltimore, and active in medicine for 28 years. She says she was born in Nagano, moved to Brazil at age 13, and later returned to Japan while searching for answers for her husband and daughter.

The Nagano scene is designed as a contradiction. Hannah's grandfather, age 92, serves foods that would scare a diabetes specialist: pie, bread, pizza, fries, and Japanese sweets. The elderly people eat freely. Hannah tests her grandfather's glucose and claims it is 108 after the meal. This moment becomes the open loop: how can elderly people eat sugar and carbs without developing diabetes?

The middle of the VSL becomes tragic. Hannah says her daughter Clara's diabetes worsened, that Clara used standard treatments, and that she died after a sudden cardiac arrest. This is the darkest emotional point of the story. It gives Hannah a personal reason to reject conventional explanations and search for alternatives.

Then comes the return to Japan, the meeting with Dr. Shinji Watanabe, and the discovery of Kongoya. The formula is introduced as simple, ancient, natural, and initially underestimated by Hannah. That skepticism is important: the VSL wants viewers to believe the narrator was not naive. She was a trained doctor who had to be convinced by results.

Finally, the villain is named. Dr. Watanabe tells Hannah that the real cause is not age, weight, stress, anxiety, diet, or lack of exercise. The cause, according to the VSL, is a parasite in the pancreas. This is the reveal the entire story is built to support.

Ads Breakdown (the specific ad angles/hooks used to drive traffic to this offer)

The ad transcript uses a classic two-step pattern: start with a familiar diabetes tip, then flip it into a deeper hidden-cause hook.

The first angle is vegetables that literally suck sugar from your blood. The ad names tomato, onion, garlic, and zucchini. It says these foods are rich in fiber, slow digestion, delay glucose absorption, help avoid insulin spikes, have a low glycemic index, and contain antioxidants and flavonoids that improve inflammation and insulin sensitivity. This opening is familiar, practical, and non-threatening. It sounds like standard nutrition content.

Then the ad pivots: if you already eat all this and glucose remains high, the problem is not your food. That is the bridge into the VSL. The ad says the problem is what is inside the pancreas.

The second angle is the diabetic worm. The ad claims Hannah Yano discovered that these vegetables do not work if the viewer has the so-called verme diabetico lodged in the body. It says the parasite devours nutrients and stops insulin from working. This turns the viewer's failure into a hidden biological sabotage story. The viewer is not blamed for eating wrong. The villain is internal.

The third angle is you do not need more diet or exercise. This is highly appealing to people exhausted by restriction. The ad says the viewer needs to remove the parasite, not eat more salad. This directly attacks the burden of conventional lifestyle advice.

The fourth angle is a 10-second Japanese trick. This phrase makes the solution sound fast, exotic, simple, and easy to try at home. It also avoids sounding like a product pitch at first. The viewer is invited to learn a trick or ritual.

The fifth angle is authority plus media framing. The ad says Hannah gave a full interview on Bem-Estar Brasil explaining the trick. It also calls her a researcher from an institute in Harvard. This differs from the main VSL's Johns Hopkins backstory, but the purpose is the same: borrowed credibility.

The sixth angle is Saiba Mais as low-friction CTA. The ad does not ask the viewer to buy immediately. It says to tap Saiba Mais to watch the complete interview and learn the tutorial. That lowers resistance and moves the viewer into the longer VSL environment.

Psychological Triggers and Persuasion Tactics

The strongest trigger in the Glicongoya VSL is fear. The transcript names blindness, amputation, wounds, neuropathy, pancreatic damage, heart attack, and cancer. The audience is pushed to see diabetes not as a chronic condition to monitor, but as a countdown toward catastrophe if the hidden parasite remains.

The second major trigger is the unique mechanism. The VSL tells viewers that diet, exercise, metformin, insulin, and Ozempic may fail because they do not touch the true cause. This is a common direct-response structure: when the audience has tried many solutions, the copy introduces a new mechanism that explains every previous failure.

The third trigger is authority stacking. Hannah Yano is presented as a doctor with Johns Hopkins training. Dr. Watanabe is presented as a respected 88-year-old naturopath. The story references a Tokyo health conference, the Chinese Academy of Sciences, and, in the ad, Harvard. Dr. Lair Ribeiro is mentioned as someone whose video was removed. Each name or institution adds perceived weight, even though the transcript does not provide verifiable citations.

The fourth trigger is conspiracy and censorship. The opening testimonial says rich pharmacy owners do not want people cured. Hannah's section says the pharmaceutical industry profits from suffering. The VSL claims Chinese findings were suppressed and that the video may be removed. This helps explain why the audience has allegedly never heard of the mechanism before.

The fifth trigger is exotic discovery. Japan and Nagano function as symbols of longevity, tradition, and hidden wisdom. The VSL contrasts Western medicine with Japanese ancestral knowledge. It suggests that elderly people in Nagano can eat sweets without diabetes because they know something outsiders do not.

The sixth trigger is relief from blame. Many diabetes pitches focus on food discipline. This one says the viewer's problem may not be lack of willpower. The villain is a parasite, not the person. That can feel emotionally liberating.

The seventh trigger is dramatic proof through body evidence. The testimonial claims the woman saw a white worm-like object in the toilet. That visual is memorable and disturbing. It creates a concrete image for an otherwise invisible mechanism.

Scientific and Authority Signals

The VSL uses many science and authority signals, but the transcript does not provide enough detail to verify them.

Hannah Yano is described as a doctor specializing in nutrition and health, trained at Johns Hopkins in 1996, with 28 years of practice. She says she attends conferences, gives interviews, and dedicates her life to lectures about her discoveries. These are credibility markers, but the transcript does not include a license number, publication record, clinic name, or link.

The ad says Hannah is a researcher at an institute in Harvard. That is a separate authority claim from the main VSL's Johns Hopkins story. The transcript does not reconcile the two.

Dr. Shinji Watanabe is presented as an 88-year-old naturopathic doctor in Nagano. He is portrayed as respected, altruistic, and deeply knowledgeable. He provides the Kongoya mixture and explains the parasite mechanism. Again, the transcript provides no clinic, credential verification, publication, or external reference.

The VSL mentions the Chinese Academy of Sciences and claims researchers identified 10 new types of worms and bacteria linked to common diseases, including the diabetic worm. It says the findings were suppressed by the Chinese government. No title, date, journal, research team, DOI, or study link appears in the provided transcript.

The presentation also uses numerical specificity: glucose of 108, fasting glucose above 142, post-meal spikes above 325, Carlos at 157 then 110, the testimonial at 230, then 118, then 90, and a claim that in 43% of cases the worm evolves and turns diabetes into pancreatic cancer. Specific numbers can make a story feel scientific. But numbers inside a VSL are not the same as clinical evidence.

For a research-first reader, the key issue is this: the VSL makes extraordinary claims but the provided transcript does not show extraordinary evidence. It uses authority language, place-based credibility, and scientific vocabulary, but it does not provide the documentation needed to evaluate the claims medically.

What Real Buyers Say

The main buyer-style testimonial in the transcript comes from the opening woman. She says she was diabetic and losing vision in both eyes. She describes 12 years of suffering, fear of blindness, fear of amputation, slow wound healing, burning and tingling feet, and loss of energy.

Her frustration is that she says she did what doctors told her to do. She avoided sweets, alcohol, and bread. She took medications including Glifage and metformin. Still, she says her glucose reached 230. This makes her a strong avatar for the offer: compliant, discouraged, and looking for a reason why standard advice did not work.

Her claimed results are dramatic. She says that after one week, her glucose began going down and did not pass 118. In the second week, she says it stabilized at 90 and her vision improved day by day. After 15 days, she says she saw a white worm-like object in the toilet. After one month, she says she saw better, ate cake at her son's birthday, and now buys bread every day for coffee.

The Carlos story functions like a second case study, though it is told by Hannah rather than directly by Carlos. Carlos is described as a 59-year-old man with type 2 diabetes, worsening glucose, fatigue, neuropathy, and a leg wound. According to Hannah, after taking the Kongoya mixture, he had less weakness and thirst by day seven, glucose around 110 by day 12, wound improvement by day 20, and full wound healing after one month.

The Nagano elders serve as community proof. Hannah's grandfather and his friends, all over 80, are described as eating sweets and carbs without developing diabetes. Her grandfather's glucose is claimed to be 108 after the meal.

These stories are emotionally compelling, but they are not independent proof. There are no medical records, lab reports, physician notes, product batch details, or follow-up data in the transcript. The testimonials should be read as claims made by the sales presentation.

The Offer / Pricing / Risk Reversal

The provided transcript does not include the commercial close. There is no stated Glicongoya price, no package count, no bottle size, no subscription terms, no shipping policy, and no refund guarantee.

That means several buyer questions remain unanswered. Is Glicongoya sold as a capsule, powder, tincture, tea, or recipe? Is the consumer buying a finished supplement or instructions to prepare the mixture? What are the exact dosages? Are there warnings for people taking diabetes medication, insulin, blood thinners, or other prescriptions? Is there a certificate of analysis? Where is it manufactured? Is there a money-back guarantee?

The VSL does use price anchoring indirectly. It repeatedly contrasts the method with expensive medications and pharmaceutical profits. It mentions Ozempic, metformin, insulin, and pharmacy owners. This framing makes the natural method feel like a more empowering alternative, even before any actual price appears.

The risk reversal in the provided transcript is emotional, not commercial. Hannah says she initially believed the mixture was natural and did not present risks, so she decided it was worth trying. That is not the same as a documented safety profile or refund guarantee.

The urgency is clearer. The opening testimonial says the doctor's video may be removed, that powerful interests will find a way to take it down, and that viewers should watch while it is still online. This is a scarcity tactic based on potential censorship rather than limited inventory.

Who This Is For (and Who It Isn't)

Based on the transcript, Verme no Pancreas - Glicongoya is aimed at people with type 2 diabetes or blood sugar concerns who feel failed by standard approaches. The ideal viewer is someone who has tried diet changes, stopped eating sweets, reduced bread, used medications, monitored glucose, and still sees high readings.

It is also aimed at caregivers. The VSL repeatedly uses family pain: grandchildren, children caring for a parent, a mother losing her daughter, a husband declining after grief, and relatives passing the video along. The call to action specifically asks viewers to share the video with a relative or friend who suffers from diabetes.

The offer is most emotionally tuned to older viewers who fear complications such as vision loss, amputation, neuropathy, and slow wound healing. It also speaks to people who are suspicious of pharmaceutical companies or frustrated by long-term medication dependence.

This is not for someone looking for a transparent ingredient label, published clinical trial evidence, cautious medical language, or a conventional diabetes education resource. The transcript does not provide enough factual documentation to support the more extraordinary claims.

It is also not for anyone who would interpret the VSL as permission to stop prescribed medication. Diabetes medications, insulin, and glucose monitoring should not be changed based on a sales video. The presentation itself attacks conventional treatment, but a responsible reader should treat that framing carefully and discuss any supplement or dietary change with a qualified clinician.

Frequently Asked Questions

What is Verme no Pancreas - Glicongoya?

Verme no Pancreas - Glicongoya is a diabetes VSL offer centered on a claimed Japanese herbal mixture called Kongoya or Glicongoya. According to the presentation, the mixture contains seven Japanese herbs and targets a so-called diabetic worm in the pancreas.

Does the transcript disclose the full Glicongoya ingredient list?

No. The transcript names Goya, identified as melao de Sao Caetano, and says the formula includes seven Japanese herbs. It does not name all seven herbs or provide dosages, extract types, safety warnings, or label details.

What is the diabetic worm claim in the VSL?

The VSL claims that a hidden parasite called suizobenchu, uratrema pancreaticum, or verme diabetico lodges in the pancreas, damages beta cells, blocks insulin function, and causes uncontrolled glucose. This is the presentation's claim, not a verified conclusion from the transcript.

What results does the presentation claim?

The opening testimonial claims glucose dropped below 118 in one week and stabilized at 90 in the second week. The Carlos story claims glucose around 110 by day 12 and wound healing within about one month. These are sales-video claims, not independently verified outcomes.

Is a price mentioned in the transcript?

No. The provided transcript does not disclose price, package options, subscription terms, refund policy, or guarantee.

What ad hooks are used to promote the offer?

The ad begins with vegetables that help with blood sugar, then pivots to the claim that diet does not work if a parasite is inside the pancreas. It promotes a 10-second Japanese trick, Hannah Yano's authority, and a Saiba Mais click to watch the full explanation.

Who is Hannah Yano in the presentation?

Hannah Yano is presented as a 53-year-old doctor specializing in nutrition and health, trained at Johns Hopkins, born in Nagano, and practicing for 28 years. The ad also references Harvard, but the main VSL emphasizes Johns Hopkins.

Does the VSL provide scientific citations?

The VSL references a Tokyo conference and the Chinese Academy of Sciences, but it does not provide study names, journal citations, author lists, publication dates, or links in the provided transcript.

Final Take

Verme no Pancreas - Glicongoya is a high-intensity diabetes VSL that sells through a dramatic hidden-cause story. Its core message is that uncontrolled glucose is not really about sugar, bread, age, stress, weight, or genetics. According to the presentation, the true cause is a worm in the pancreas, and the answer is a Japanese herbal mixture centered on Goya / melao de Sao Caetano.

From a marketing perspective, the offer is built with strong direct-response architecture: a suffering testimonial, a tragic doctor backstory, exotic Japanese authority, a simple ritual, a hidden villain, censorship urgency, and before-and-after glucose numbers. The ad funnel supports the same idea by beginning with practical vegetable advice and then claiming that diet fails when the verme diabetico is present.

From an editorial and research perspective, the biggest issue is evidence. The transcript does not disclose the full ingredient list, does not state price, does not provide a guarantee, and does not cite verifiable clinical studies for the diabetic worm mechanism. The claims about glucose normalization, parasite elimination, wound healing, and diabetes reversal are presented inside the VSL, but they are not independently substantiated in the provided material.

The safest reading is this: Glicongoya is positioned as a natural Japanese blood sugar solution with a parasite-removal mechanism, but the transcript leaves major factual, scientific, and commercial questions unanswered. Anyone dealing with diabetes should treat the presentation as marketing content, not medical guidance, and should not alter prescribed treatment based on the VSL.

Disclaimer: This article is for research and educational purposes only. It is not medical, legal, or financial advice, and it is not affiliated with the product or its makers. Always consult a qualified professional before making health or financial decisions.